Northwest & Ethical Investments L.P. Abb Vie Inc. Transaction History
Northwest & Ethical Investments L.P.
- $3.68 Trillion
- Q4 2024
A detailed history of Northwest & Ethical Investments L.P. transactions in Abb Vie Inc. stock. As of the latest transaction made, Northwest & Ethical Investments L.P. holds 195,450 shares of ABBV stock, worth $38.4 Million. This represents 0.94% of its overall portfolio holdings.
Number of Shares
195,450
Previous 189,075
3.37%
Holding current value
$38.4 Million
Previous $37.3 Billion
6.98%
% of portfolio
0.94%
Previous 0.99%
Shares
3 transactions
Others Institutions Holding ABBV
# of Institutions
4,078Shares Held
1.28BCall Options Held
16.9MPut Options Held
15.1M-
Vanguard Group Inc Valley Forge, PA173MShares$34 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$26.8 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.6MShares$15.6 Billion0.57% of portfolio
-
Jpmorgan Chase & CO New York, NY51.8MShares$10.2 Billion0.75% of portfolio
-
Morgan Stanley New York, NY39.7MShares$7.79 Billion0.51% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $347B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...